Michael P. Jones
Michael P. Jones
Verified email at mq.edu.au
Title
Cited by
Cited by
Year
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
NC Arbour, E Lorenz, BC Schutte, J Zabner, JN Kline, M Jones, K Frees, ...
Nature genetics 25 (2), 187-191, 2000
23622000
MCMC-based particle filtering for tracking a variable number of interacting targets
Z Khan, T Balch, F Dellaert
IEEE transactions on pattern analysis and machine intelligence 27 (11), 1805 …, 2005
9782005
Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15 000 adults
P Bytzer, NJ Talley, M Leemon, LJ Young, MP Jones, M Horowitz
Archives of internal medicine 161 (16), 1989-1996, 2001
6392001
Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study
M Camilleri, D Dubois, B Coulie, M Jones, PJ Kahrilas, AM Rentz, ...
Clinical Gastroenterology and Hepatology 3 (6), 543-552, 2005
3842005
The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study
NA Koloski, M Jones, J Kalantar, M Weltman, J Zaguirre, NJ Talley
Gut 61 (9), 1284-1290, 2012
3622012
Does colchicine work? The results of the first controlled study in acute gout
MJ Ahern, C Reid, TP Gordon, M McCredle, PM Brooks, M Jones
Australian and New Zealand journal of medicine 17 (3), 301-304, 1987
3351987
The accuracy of clinical symptoms and signs for the diagnosis of serious bacterial infection in young febrile children: prospective cohort study of 15 781 febrile illnesses
JC Craig, GJ Williams, M Jones, M Codarini, P Macaskill, A Hayen, L Irwig, ...
Bmj 340, c1594, 2010
3272010
Non‐cardiac chest pain: prevalence, risk factors, impact and consulting—a population‐based study
GD Eslick, MP Jones, NJ Talley
Alimentary pharmacology & therapeutics 17 (9), 1115-1124, 2003
3242003
Violence and aggression in psychiatric units
C Owen, C Tarantello, M Jones, C Tennant
Psychiatric Services 49 (11), 1452-1457, 1998
3221998
Does gestational hypertension become pre‐eclampsia?
P Saudan, MA Brown, ML Buddle, M Jones
BJOG: An International Journal of Obstetrics & Gynaecology 105 (11), 1177-1184, 1998
3071998
In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors.
P Lemarchand, M Jones, I Yamada, RG Crystal
Circulation research 72 (5), 1132-1138, 1993
2991993
Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus
J Lawrence, DL Mayers, KH Hullsiek, G Collins, DI Abrams, RB Reisler, ...
New England Journal of Medicine 349 (9), 837-846, 2003
2952003
Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population
NJ Talley, P Boyce, M Jones
Gut 42 (5), 690-695, 1998
2921998
Predictors of health care seeking for irritable bowel syndrome: a population based study
NJ Talley, PM Boyce, M Jones
Gut 41 (3), 394-398, 1997
2891997
Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia?
NJ Talley, M Verlinden, M Jones
The American journal of gastroenterology 96 (5), 1422-1428, 2001
2762001
Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study
L Agréus, K Svärdsudd, NJ Talley, MP Jones, G Tibblin
The American journal of gastroenterology 96 (10), 2905-2914, 2001
2752001
Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15 183 recipients
AC Webster, JC Craig, JM Simpson, MP Jones, JR Chapman
American Journal of Transplantation 7 (9), 2140-2151, 2007
2612007
Variable airway responsiveness to inhaled lipopolysaccharide
JN Kline, JD Cowden, GW Hunninghake, BC Schutte, JL Watt, ...
American journal of respiratory and critical care medicine 160 (1), 297-303, 1999
2611999
Population prevalence of the MELAS A3243G mutation
N Manwaring, MM Jones, JJ Wang, E Rochtchina, C Howard, P Mitchell, ...
Mitochondrion 7 (3), 230-233, 2007
2512007
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
M Martin, FA Holmes, B Ejlertsen, S Delaloge, B Moy, H Iwata, ...
The Lancet Oncology 18 (12), 1688-1700, 2017
2492017
The system can't perform the operation now. Try again later.
Articles 1–20